News
The clinical alarm management market is growing at a significant CAGR of around 14-17% over the forecast period. The primary ...
The global digital biomarkers market is set to witness a growth rate of 20% in the next 5 years. Rising prevalence of chronic ...
Overview of Platelet Aggregation Devices MarketThe global Platelet Aggregation Devices Market is valued at USD 590.65 Million ...
Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and ...
Overview of Contraceptive Drugs MarketThe Global Contraceptive Drugs Market is valued at USD 19.80 Billion in 2024 and is ...
Patent Filing: MDCE Seeks to Revolutionize Healthcare and Authentication With AI Photo Matching Tech
Billion Dollar Healthcare and Digital Memorabilia Authentication Markets MESA, ARIZONA / ACCESS Newswire / August 1, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a forward-thinking innovator ...
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13)Updates 2025 projected revenue range to $1.5 to $2.2 billion, reflecting a $300 million ...
Black Book Research Unveils Comprehensive Intelligence Guide Offering Strategic Pathways, Vendor Benchmarks, and Cybersecurity Imperatives for Hospitals Worldwide NEW YORK CITY, NY / ACCESS Newswire / ...
Multiple U.S. Judges Dismiss Actions Against EESystem, Affirming Company's Right to Protect Its Reputation LAS VEGAS, NV / ACCESS Newswire / August 1, 2025 / Energy Enhancement System ("EESystem") ...
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal has upheld the validity of Moderna's EP'949 patent.This decision affirms the ...
The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by increasing demand for high-specificity antibodies, assay-ready reagents, and ...
Cash burn of $3.8 million in Q2 remains in line with projected quarterly range- Cash and investments are sufficient to fund operations through Q3'2026 at current cash burn rate- Commercial readiness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results